Analysen von Michael Leuchten

14.04.23		Sartorius vz. Buy	UBS AG
30.03.23		Sanofi Neutral	UBS AG
28.03.23		Novartis Neutral	UBS AG
28.03.23		Bayer Buy	UBS AG
23.03.23		Sanofi Neutral	UBS AG
14.03.23		Sanofi Neutral	UBS AG
10.03.23		AstraZeneca Neutral	UBS AG
09.03.23		Sartorius vz. Buy	UBS AG
Werbung
03.03.23		Roche Neutral	UBS AG
02.03.23		Merck Buy	UBS AG
28.02.23		Bayer Buy	UBS AG
21.02.23		AstraZeneca Neutral	UBS AG
10.02.23		AstraZeneca Neutral	UBS AG
10.02.23		Sartorius vz. Buy	UBS AG
09.02.23		Bayer Buy	UBS AG
07.02.23		Roche Neutral	UBS AG
06.02.23		Sanofi Neutral	UBS AG
01.02.23		Novo Nordisk Sell	UBS AG
01.02.23		GSK Sell	UBS AG
01.02.23		Novartis Neutral	UBS AG
26.01.23		Sartorius vz. Buy	UBS AG
20.01.23		Novo Nordisk Sell	UBS AG
20.01.23		Roche Neutral	UBS AG
18.01.23		GSK Sell	UBS AG
11.01.23		Bayer Buy	UBS AG
09.01.23		AstraZeneca Neutral	UBS AG
09.01.23		Sartorius vz. Buy	UBS AG
09.01.23		Sanofi Neutral	UBS AG
09.01.23		Roche Neutral	UBS AG
09.01.23		Novartis Neutral	UBS AG
09.01.23		Novo Nordisk Sell	UBS AG
09.01.23		GSK Sell	UBS AG
09.01.23		Bayer Buy	UBS AG
09.01.23		Merck Buy	UBS AG
14.12.22		Novartis Neutral	UBS AG
14.12.22		Roche Neutral	UBS AG
14.12.22		Sanofi Neutral	UBS AG
14.12.22		Merck Buy	UBS AG
12.12.22		Sanofi Neutral	UBS AG
07.12.22		GSK Sell	UBS AG
06.12.22		Novartis Neutral	UBS AG
01.12.22		Sanofi Neutral	UBS AG
21.11.22		Sanofi Neutral	UBS AG
14.11.22		Roche Neutral	UBS AG
11.11.22		GSK Sell	UBS AG
10.11.22		AstraZeneca Neutral	UBS AG
10.11.22		Merck Neutral	UBS AG
08.11.22		Bayer Buy	UBS AG
02.11.22		GSK Neutral	UBS AG
02.11.22		Novo Nordisk Sell	UBS AG